112
Views
48
CrossRef citations to date
0
Altmetric
Original Paper

Impact of Conventional Chemotherapy on Levels of Antibodies Against Vaccine-Preventable Diseases in Children Treated for Cancer

, , , &
Pages 851-857 | Received 16 Apr 2003, Accepted 11 Aug 2003, Published online: 08 Jul 2009

References

  • Feldman S, Cox F. Viral infections and haematological malignancies. Clin Haematol 1976; 5: 311–28.
  • Ridgway D, Wolff LJ. Active immunisation of children with leukaemia and other malignancies. Leuk Lymphoma 1993; 9: 177–92.
  • Alanko S, Pelliniemi TT, Salmi TT. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukaemia. Cancer 1992; 69: 1481–6.
  • Alanko S, Salmi TT, Pelliniemi TT. Recovery of blood T-cell subsets after chemotherapy for childhood acute lymphoblastic leukaemia. Pediatr Hematol Oncol 1994; 11: 281–92.
  • Alanko S, Salmi TT, Pelliniemi TT. Recovery of natural killer cells after chemotherapy for childhood acute lymphoblastic leukaemia and solid tumours. Med Pediatr Oncol 1995; 24: 373–8.
  • Atra A, Richards SM, Chessells JM. Remission death in acute lymphoblastic leukaemia: a changing pattern. Arch Dis Child 1993; 69: 550–4.
  • de Boer AW, de Vaan GA. Mild course of mumps in patients with acute lymphoblastic leukaemia. Eur J Pediatr 1989; 148: 618–9.
  • Geiger R, Fink FM, Solder B, Sailer M, Enders G. Persistent rubella infection after erroneous vaccination in an immunocompromised patient with acute lymphoblastic leukaemia in remission. J Med Virol 1995; 47: 442–4.
  • Rajouria VP, Johnston JH. Tetanus complicating acute leukaemia--a case report. Ann Trop Med Parasitol 1982; 76: 247.
  • Pauksen K, Duraj V, Ljungman P, Sjolin J, Oberg G, Lonnerholm G, et al. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplant 1992; 9: 427–32.
  • Pezzini C, Limonta M, Rovelli A, Uderzo C, Locasciulli A, Maglia O, et al. Immunity to polioviruses and tetanus after bone marrow transplantation in children. Pediatr Hematol Oncol 1994; 11: 331–6.
  • von der Hardt K, Jüngert J, Beck JD, Heininger U. Humoral immunity against diphtheria, tetanus and poliomyelitis after antineoplastic therapy in children and adolescents: a retrospective analysis. Vaccine 2000; 18: 2999–3004.
  • Nilsson A, De Milito A, Engstrom P, Nordin M, Narita M, Grillner L, et al. Current chemotherapy protocols for childhood acute lymphoblastic leukaemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics, : e91 2001; 109: 1–6.
  • Marek-Bérard P, Floret D, Schell M, Mialou V, Frapatz D, Philip T, Bergeron C. Vaccination de l’enfant traité pour tumeur solide : quelle conduite à tenir? Arch Pediatr 2001; 8: 734–43.
  • Li Volti S, Giammanco-Bilancia G, Grassi M, Garozzo R, Gluck R, Giammanco G. Duration of the immune response to MMR vaccine in children of two age-different groups. Eur J Epidemiol 1993; 9: 311–4.
  • Miller E, Hill A, Morgan-Capner P, Forsey T, Rush M. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines. Vaccine 1995; 13: 799–802.
  • Schettini F, Manzionna MM, De Mattia D, Amendola F, Di Bitonto G. Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps. Minerva Pediatr 1989; 41: 117–22.
  • Stark K, Schonfeld C, Barg J, Molz B, Vornwald A, Bienzle U. Seroprevalence and determinants of diphtheria, tetanus and poliomyelitis antibodies among adults in Berlin, Germany. Vaccine 1999; 17: 844–50.
  • Siber GR. Methods for estimating serological correlates of protection. Dev Biol Stand 1997; 89: 283–96.
  • Skoura L, Efstratiou A, Tsakris A, Pournaras S, George RC, Douboyas J. Study on the use of an enzyme-linked immunosorbent assay in determining human antibodies to diphtheria toxin as compared with a reference toxin neutralising assay. Comp Immunol Microbiol Infect Dis 1999; 22: 181–6.
  • Walory J, Grzesiowski P, Hryniewicz W Comparison of four serological methods for the detection of diphtheria antitoxin antibody. J Immunol Meth 2000; 245: 55–65.
  • Mustafa MM, Buchanan GR, Winick NJ, McCracken GH, Tkaczewski I, Lipscomb M, et al. Immune recovery in children with malignancy after cessation of chemotherapy. J Pediatr Hematol Oncol 1998; 20: 451–7.
  • Zinkernagel RM. Felix Hoppe-Seyler Lecture . Protective antibody responses against viruses. Biol Chem ; 378 1997; 1997: 725–9.
  • Funk GA, Barbour AD, Hengartner H, Kalinke U. Mathematical model of a virus-neutralising immunglobulin response. J Theor Biol 1998; 195: 41–52.
  • Torigoe S, Hirai S, Oitani K, Ito M, Ihara T, Iwasa T, et al. Application of live attenuated measles and mumps vaccines in children with acute leukaemia. Biken J 1981; 24: 147–51.
  • van den Does-van den Berg A, Hermans J, Nagel J, van Steenis G. Immunity to diphtheria, pertussis, tetanus, and poliomyelitis in children with acute lymphocytic leukaemia after cessation of chemotherapy. Pediatrics 1981; 67: 222–9.
  • King SM, Saunders EF, Petric M, Gold R. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. Bone Marrow Transplant 1996; 17: 633–6.
  • Smith S, Schiffman G, Karayalcin G, Bonagura V Immunodeficiency in long-term survivors of acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Munster therapy. J Pediatr 1995; 127: 68–75.
  • Hovi L, Valle M, Siimes MA, Jalanko H, Saarinen UM. Impaired response to hepatitis B vaccine in children receiving anticancer chemotherapy. Pediatr Infect Dis J 1995; 14: 931–5.
  • Ridgway D, Wolff LJ, Deforest A. Immunisation response varies with intensity of acute lymphoblastic leukaemia therapy. Am J Dis Child 1991; 145: 887–91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.